₹25,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 5 Years
If you had started a ₹25,000/month SIP on 1 Oct 2021 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 61 installments.
You invested
₹15,25,000
61 installments
Value today
₹22,38,546
1 Oct 2026
Absolute gain
+₹7,13,546
+46.8%
XIRR (annualised)
15.57%
money-weighted
The journey, month by month
Worst fall on the way
-13.4%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹17,88,943
Modelled at historical FD rates. The fund beat FD by ₹4,49,603.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (3 Oct 2022) | ₹3,25,000 | ₹3,23,996 | -0.3% |
| Year 2 (3 Oct 2023) | ₹6,25,000 | ₹7,52,492 | +20.4% |
| Year 3 (1 Oct 2024) | ₹9,25,000 | ₹14,83,858 | +60.4% |
| Year 4 (1 Oct 2025) | ₹12,25,000 | ₹17,24,546 | +40.8% |
| Year 5 (1 Oct 2026) | ₹15,25,000 | ₹22,38,546 | +46.8% |
Best year of the journey: Year 3 (+41% market move) · Toughest year: Year 4 (-3.3%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 1 Oct 2021 and 1 Oct 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.